Iso-α-acids, the bitter components of beer, improve hippocampus-dependent memory through vagus nerve activation.


Journal

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
ISSN: 1530-6860
Titre abrégé: FASEB J
Pays: United States
ID NLM: 8804484

Informations de publication

Date de publication:
04 2019
Historique:
pubmed: 3 1 2019
medline: 14 1 2020
entrez: 3 1 2019
Statut: ppublish

Résumé

Iso-α-acids (IAAs) are hop-derived bitter acids of beer. Epidemiologic studies suggest that moderate alcohol consumption is beneficial for cognitive function, but they do not show the ingredients in alcoholic beverages. Previously, we reported that long-term consumption of IAAs prevents inflammation and Alzheimer pathologies in mice, but their effects on cognitive function have not been evaluated. In the present study, we demonstrated that the consumption of IAAs improves spatial and object recognition memory functions not only in normal Crl:CD1(ICR) male mice but also in mice with pharmacologically induced amnesia. IAA consumption increased the total and extracellular levels of dopamine in the hippocampus of mice and Sprague-Dawley male rats, respectively. Dopamine D

Identifiants

pubmed: 30601670
doi: 10.1096/fj.201801868RR
pmc: PMC6436653
doi:

Substances chimiques

Acids 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4987-4995

Références

Curr Opin Neurobiol. 2004 Jun;14(3):311-7
pubmed: 15194111
Proc Natl Acad Sci U S A. 2016 Dec 20;113(51):14835-14840
pubmed: 27930324
Neurobiol Learn Mem. 2012 Feb;97(2):271-5
pubmed: 22266268
Chem Senses. 2011 Mar;36(3):311-9
pubmed: 21163912
J Pharmacol Exp Ther. 2006 Aug;318(2):890-8
pubmed: 16690723
J Neurosci. 1998 Dec 1;18(23):10037-44
pubmed: 9822758
Synapse. 2018 Aug;72(8):e22033
pubmed: 29537707
Learn Mem. 2009 Dec 22;17(1):5-11
pubmed: 20028732
Neurobiol Aging. 2018 Dec;72:23-31
pubmed: 30176402
Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):2392-7
pubmed: 11854532
J Neurosci. 1999 May 1;19(9):3535-44
pubmed: 10212313
J Biol Chem. 2017 Mar 3;292(9):3720-3728
pubmed: 28087694
Neurology. 2015 Jan 20;84(3):287-95
pubmed: 25503981
Learn Mem. 2002 Jul-Aug;9(4):156-66
pubmed: 12177229
Front Psychiatry. 2015 Mar 24;6:43
pubmed: 25852579
Brain Stimul. 2017 Nov - Dec;10(6):1045-1054
pubmed: 28918943
Mol Psychiatry. 2018 Aug;23(8):1717-1730
pubmed: 28924188
Neural Plast. 2017;2017:8602690
pubmed: 29123927
J Agric Food Chem. 2013 Mar 27;61(12):3121-30
pubmed: 23469991
Eur J Neurosci. 2017 Jan;45(1):138-146
pubmed: 27646422
Brain Res. 2007 Nov 7;1179:28-34
pubmed: 17920573
Am J Physiol. 1997 Apr;272(4 Pt 2):R1245-51
pubmed: 9140026
Mol Interv. 2008 Apr;8(2):78-81
pubmed: 18403652
Behav Brain Res. 2017 Mar 15;321:61-68
pubmed: 28025067
Biochem J. 2011 Aug 15;438(1):33-7
pubmed: 21592089
Nat Neurosci. 2003 May;6(5):526-31
pubmed: 12704392
Behav Brain Res. 2014 Sep 1;271:212-7
pubmed: 24959860
Behav Brain Res. 2014 Mar 15;261:249-57
pubmed: 24333574
J Neurosci. 2014 Jun 4;34(23):7862-70
pubmed: 24899709
J Neurosci. 2000 Nov 1;20(21):8177-87
pubmed: 11050141
Acta Neurol Scand Suppl. 2010;(190):23-9
pubmed: 20586731
Nature. 2016 Sep 15;537(7620):357-362
pubmed: 27602521
Nihon Rinsho. 2011 Dec;69 Suppl 10 Pt 2:217-22
pubmed: 22755187
J Clin Invest. 2008 Nov;118(11):3693-700
pubmed: 18846256
Sci Rep. 2018 Mar 19;8(1):4760
pubmed: 29555941
Neuropsychiatr Dis Treat. 2011;7:465-84
pubmed: 21857787
Learn Mem. 2007 Mar 02;14(3):117-25
pubmed: 17337702
Eur J Pharmacol. 2017 Dec 15;817:86-95
pubmed: 28549787
Front Synaptic Neurosci. 2016 Sep 23;8:31
pubmed: 27721791
Behav Brain Res. 2015 May 15;285:105-17
pubmed: 25169255
J Clin Endocrinol Metab. 2001 Dec;86(12):5830-7
pubmed: 11739447
Nat Commun. 2018 Jun 5;9(1):2181
pubmed: 29872139
PLoS One. 2015 Aug 14;10(8):e0135578
pubmed: 26275140
Front Psychiatry. 2018 Mar 13;9:44
pubmed: 29593576
J Transl Med. 2016 Apr 27;14:101
pubmed: 27118204
Annu Rev Nutr. 2007;27:389-414
pubmed: 17444812

Auteurs

Yasuhisa Ano (Y)

Research Laboratories for Health Science and Food Technologies, Kirin Company, Limited, Yokohama-shi, Japan.

Ayaka Hoshi (A)

Research Laboratories for Health Science and Food Technologies, Kirin Company, Limited, Yokohama-shi, Japan.

Tatsuhiro Ayabe (T)

Research Laboratories for Health Science and Food Technologies, Kirin Company, Limited, Yokohama-shi, Japan.

Rena Ohya (R)

Research Laboratories for Health Science and Food Technologies, Kirin Company, Limited, Yokohama-shi, Japan.

Shinichi Uchida (S)

Research and Development Division, Central Nervous System Research Laboratories, Central Nervous System (CNS) Research and Development Unit, Kyowa Hakko Kirin Company, Limited, Shizuoka, Japan.

Koji Yamada (K)

Research and Development Division, Central Nervous System Research Laboratories, Central Nervous System (CNS) Research and Development Unit, Kyowa Hakko Kirin Company, Limited, Shizuoka, Japan.

Keiji Kondo (K)

Research Laboratories for Health Science and Food Technologies, Kirin Company, Limited, Yokohama-shi, Japan.

Shiho Kitaoka (S)

Division of Pharmacology, Kobe University Graduate School of Medicine, Kobe-shi, Japan; and.
Japan Agency for Medical Research and Development-Centers of Research Excellence in Science and Technology (AMED-CREST) Tokyo, Japan.

Tomoyuki Furuyashiki (T)

Division of Pharmacology, Kobe University Graduate School of Medicine, Kobe-shi, Japan; and.
Japan Agency for Medical Research and Development-Centers of Research Excellence in Science and Technology (AMED-CREST) Tokyo, Japan.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH